BioPharm News

Jul 10, 2017
By BioPharm International Editors
FDA sent a warning letter to Shandong Analysis and Test Center for CGMP violations including data integrity issues and insufficient testing procedures.
Jul 10, 2017
By BioPharm International Editors
The agency’s Pharmacovigilance Risk Assessment Committee made recommendations on the risk of multiple sclerosis treatments, injectable methylprednisolone medicines, and the use of gadolinium contrast agents.
Jul 10, 2017
By BioPharm International Editors
The National Institutes of Health says a new study showed that hydroxychloroquine reduced the transmission of Zika in pregnant mice.
Jul 10, 2017
By BioPharm International Editors
The assay assesses the ability of antibodies to neutralize the Ebola virus.
Jul 06, 2017
By BioPharm International Editors
A $5.5 billion acquisition brings Capsugel’s oral dosage delivery capabilities to Lonza’s portfolio.
Jul 05, 2017
By BioPharm International Editors
Patheon will add spray drying, sterile manufacturing, and packaging capabilities to four facilities.
Jul 05, 2017
By BioPharm International Editors
Samsung BioLogics signs $55.5 million agreement to manufacture tildrakizumab for Sun Pharma.
Jul 05, 2017
By BioPharm International Editors
A new study predicts a potential disconnect between regulatory science and biotechnology product development, unless regulators scan the horizon for new developments and consider new potential risk pathways.
Jul 05, 2017
By BioPharm International Editors
SOBI003 is a chemically modified variant of a recombinant human sulfamidase product candidate, using Sobi’s proprietary glycan modification technology.
Jul 05, 2017
By BioPharm International Editors
A Supreme Court decision and improvements in analytical processes may speed the biosimilar approval process.
native1_300x100
lorem ipsum